Complex therapy of IBD

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorAssaf, Iyad
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.date.accessioned2019-09-24T11:07:05Z
dc.date.available2019-09-24T11:07:05Z
dc.date.created2019-03-29
dc.description.abstractInflammatory bowel disease (IBD) is a chronic inflammatory disease affecting the gastrointestinal tract. It is comprised of two major groups: ULCERATIVE COLITIS and CROHN’S DISEASE. The treatment and management of IBD is complex and patient specific. It can be either medical or surgical, or in some cases a combinations of both. Due to the fact that IBD can negatively impact many aspects of the patient’s quality of life, and it is associated with high risk of complications or even mortality, the developed and wide range of treatments makes it very challenging in our clinical practice nowadays. Thanks to different approaches and newly developed drugs that can be used in several formulations, and in addition to the new techniques of surgical interventions, patients suffering from IBD can be managed and controlled in a better way to decrease their rates of complications and mortality.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent71hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/273685
dc.language.isoenhu_HU
dc.subjectIBDhu_HU
dc.subjectcrohn's disease
dc.subjectulcerative colitis
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titleComplex therapy of IBDhu_HU
Fájlok